{
  "basic_data": [
    {
      "frozen": "False",
      "cell_type": "hiPSC",
      "cell_line_alt_name": "FI.SPSM.SCN2A.R1882Q.009",
      "hpscreg_name": "FINi001-A"
    }
  ],
  "generator": [
    {
      "group": "The Florey Institute of Neuroscience and Mental Health"
    }
  ],
  "publications": [
    {
      "doi": "10.1016/j.scr.2023.103179",
      "title": "Generation of an iPSC line (FINi001-A) from a girl with developmental and epileptic encephalopathy due to a heterozygous gain-of-function p.R1882Q variant in the voltage-gated sodium channel Na(v)1.2 protein encoded by the SCN2A gene",
      "journal": "Stem cell research",
      "last_author": "Petrou S",
      "first_author": "Ovchinnikov DA",
      "year": "2023.0",
      "pmid": "37597357"
    },
    {
      "doi": "10.1016/j.scr.2023.103211",
      "title": "Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene",
      "journal": "Stem cell research",
      "last_author": "Ovchinnikov DA",
      "first_author": "Pavan C",
      "year": "2023.0",
      "pmid": "37890334"
    },
    {
      "doi": "10.1016/j.scr.2024.103367",
      "title": "An iPSC line (FINi003-A) from a male with late-onset developmental and epileptic encephalopathy caused by a heterozygous p.E1211K variant in the SCN2A gene encoding the voltage-gated sodium channel Na(v)1.2",
      "journal": "Stem cell research",
      "last_author": "Petrou S",
      "first_author": "Ovchinnikov DA",
      "year": "2024.0",
      "pmid": "38479087"
    }
  ],
  "donor": [
    {
      "sex": "F",
      "age": "1_4",
      "disease_description": "A neurological disorder characterized by recurring seizures presenting within the first three months of life and progressive cerebral dysfunction.",
      "disease_name": "Developmental and Epileptic Encephalopathy"
    }
  ],
  "genomic_modifications": [
    {
      "mutation_type": "VA",
      "loci_name": "SCN2A",
      "description": "A neurological disorder characterized by recurring seizures presenting within the first three months of life and progressive cerebral dysfunction."
    }
  ],
  "differentiation_results": [
    {
      "marker_list": "SOX17;CXCR4",
      "show_potency": "False",
      "cell_type": "EN"
    },
    {
      "marker_list": "TBXT;TBX6",
      "show_potency": "False",
      "cell_type": "ME"
    },
    {
      "marker_list": "PAX6;OTX2",
      "show_potency": "False",
      "cell_type": "EC"
    }
  ],
  "undifferentiated_characterisation": [
    {
      "epi_pluri_score": "Missing",
      "pluri_test_score": "Missing",
      "pluri_novelty_score": "Missing"
    }
  ],
  "genomic_characterisation": [
    {
      "karyotype": "46, XX",
      "karyotype_method": "MKSNP",
      "passage_number": "25"
    }
  ],
  "induced_derivation": [
    {
      "non_int_vector": "O"
    }
  ],
  "embryonic_derivation": [
    {
      "embryo_stage": "Missing",
      "zp_removal_technique": "Missing",
      "trophectoderm_morphology": "Missing",
      "icm_morphology": "Missing",
      "e_preimplant_genetic_diagnosis": "Missing"
    }
  ],
  "ethics": [
    {
      "ethics_number": "HREC/16/Austin/472",
      "approval_date": "1900-01-01",
      "institutional_HREC": "Human Research Ethics Committee of Health/Austin"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "o2_concentration": "0.2",
      "passage_method": "EF"
    }
  ]
}